Seikisui Of Japan To Expand Operations Abroad With Bestsellers
This article was originally published in PharmAsia News
Executive Summary
Japan's Seikisui Chemical announced plans to become the world's leading source for a pair of diagnostic drugs for both types of cholesterol and three other medical products. The company said it would create a new company in April to consolidate all of its medical operations and add new sales bases in the United States and Germany. Sekisui plans also include having five best-selling medical products on the global market by fiscal year 2011. (Click here for more - a subscription may be required
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.